Primary Evaluation of Anticancer Activity of Nanocurcumin® Against Human Breast Cancer Cell Line, SkBr3

Abstract

Breast cancer is a predominant ailment mostly impairing woman. Against the triple negative breast cancer xenografts, the curcumin in polymeric micelle form showed increased bioavailability, cytotoxicity and longer half-life, observed in in vitro studies (Cridge et al., 2013). In this study, in vitro anticancer activity of Nanocurcumin® was evaluated against human breast cancer.